William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $72.75 ($2.9M) on 2025-06-10, disclosed to the SEC on 2025-06-12.
Scheduled sale ($2.9M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.36 | 16,918 | $1.2M | 42.3% |
| 2 | $72.36 | 16,918 | $1.2M | 42.3% |
| 3 | $72.75 | 3,082 | $224K | 7.7% |
| 4 | $72.75 | 3,082 | $224K | 7.7% |
| Total | $72.42 avg | 40,000 | $2.9M | 100% |
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |